Jerzy Kawiak

Jerzy Kawiak

Auto-generated profile, based on publicly available information

Jerzy Kawiak

Polish Academy of Science

Research Focus & Metrics

Academic Career Length

72Years (1955-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2015 in Stem Cell Research & Therapy
Verified
Journal Article
Open access
PDF file
TSTomasz Skirecki
Tomasz Skirecki
JKJerzy Kawiak
Jerzy Kawiak
EMEugeniusz Machaj
Eugeniusz Machaj
ZPZygmunt Pojda
Zygmunt Pojda
DWDanuta Wasilewska
Danuta Wasilewska
GHGrazyna Hoser
Grazyna Hoser
Introduction: An effective immune response to severe bacterial infections requires a robust production of the innate immunity cells from hematopoietic stem and progenitor cells (HSPCs) in a process called emergency myelopoiesis. In sepsis, an altered immune response that leads to a failure of bacterial clearance is often observed. In this study, we aimed to evaluate the impact of sepsis on human HSPCs in the bone marrow (BM) microenvironment of humanized mice subjected to acute endotoxemia and polymicrobial sepsis. Methods: Humanized mice (hu-NSG) were generated by transplanting NOD.Cg-Prkdc/scidIL2rγ (NSG) mice with the human cord blood CD34+ cells. Eight weeks after the transplantation, hu-NSG mice were subjected to sepsis induced by endotoxemia—Escherichia coli lipopolysaccharide (LPS)—or by cecal ligation and puncture (CLP). Twenty-four hours later, HSPCs from BM were analyzed by flow cytometry and colony-forming unit (CFU) assay. CLP after inhibition of Notch signaling was also performed. The effects of LPS on the in vitro proliferation of CD34+ cells from human BM were tested by CellTrace Violet dye staining. Results: The expression of Toll-like receptor 4 receptor was present among engrafted human HSPCs. Both CLP and endotoxemia decreased (by 43 % and 37 %) cellularity of the BM. In addition, in both models, accumulation of early CD34+ CD38− HSCs was observed, but the number of CD34+ CD38+ progenitors decreased. After CLP, there was a 1.5-fold increase of proliferating CD34+ CD38−Ki-67+ cells. Moreover, CFU assay revealed a depressed (by 75 % after LPS and by 50 % after CLP) production of human hematopoietic colonies from the BM of septic mice. In contrast, in vitro LPS stimulated differentiation of CD34+ CD38− HSCs but did not induce proliferation of these cells in contrast to the CD34+ CD38+ progenitors. CLP sepsis modulated the BM microenvironment by upregulation of Jagged-1 expression on non-hematopoietic cells, and the proliferation of HSCs was Notch-dependent. Conclusions: CLP sepsis and endotoxemia induced a similar expansion and proliferation of early HSCs in the BM, while committed progenitors decreased. It is suggestive that the Notch pathway contributed to this effect. Targeting early hematopoiesis may be considered as a viable alternative in the existing arsenal of supportive therapies in sepsis.

1 April 1971 in Biochimica et Biophysica Acta (BBA) - Enzymology
Verified
Journal Article
Closed access
JKJerzy Kawiak
Jerzy Kawiak
WVWilliam H. Vensel
William H. Vensel
JKJanusz Komender
Janusz Komender
EBEric A. Barnard
Eric A. Barnard

10 October 2014 in Folia Histochemica et Cytobiologica
Verified
Journal Article
Open access
ZGZofia Grzywocz
Zofia Grzywocz
EPEwa Pius-Sadowska
Ewa Pius-Sadowska
PKPatrycja Kłos
Patrycja Kłos
MGMarek Gryzik
Marek Gryzik
DWDanuta Wasilewska
Danuta Wasilewska
JKJerzy Kawiak
Jerzy Kawiak
In vitro studies have shown that amnion-produced growth factors participated in angiogenesis, re-epithelialization, and immunomodulation. The aim of our study was to investigate the growth factors and receptors produced by human amnion tissue and amniotic cells. Human amnions (hAM) were isolated, and amnion circles were dissected for in vitro analysis. Some amnion fragments were digested by the use of different methods to obtain two cell fractions, which were analysed for mesenchymal and epithelial cell markers. Amniotic circles and human amniotic cell fractions were cultured in a protein-free medium. Proteins secreted into the culture medium were analysed with a human growth factor antibody array. Conditioned culture media were added to human umbilical vein epithelial cells (HUVECs) to test for stimulation of migration (scratch test) and proliferation (Ki67 expression). Fraction 1 cells expressed both cytokeratin and mesenchymal cell markers which indicated that it was composed of a mixture of human amnion epithelial cells (hAECs) and mesenchymal stromal cells (hAMSCs). Fraction 2 cells mainly expressed cytokeratin and, therefore, were designed as hAECs. Secretion of proteins by the cultured cells increased with time. The hAM cultures secreted EGF-R, IGF, and IGFBP-2,-3 and -6; Cell Fraction 1 secreted NT-4, whereas Cell Fraction 2 secreted G-CSF, M-CSF, and PDGF. Conditioned media of hAM cultures stimulated HUVECs migration. We have showed for the first time that human amnions and amniotic cells secreted IGFBP-6, MCSF-R, PDGF-AB, FGF-6, IGFBP-4, NT-4, and VEGF-R3. We found that Cell Fraction 1, Cell Fraction 2, and the whole amnion secreted different proteins, possibly due to different proportions of amnion-derived cells and different cell-cell interactions. The hAM cell factors remained functional in vitro and induced intensified migration of HUVECs. The growth factors and receptors found in amnion or amniotic cell media might be used for regenerative medicine.

15 January 1997 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
PDF file
TSTomasz Skorski
Tomasz Skorski
MNM. Nieborowska-Skorska
M. Nieborowska-Skorska
PWPawel K. Wlodarski
Pawel K. Wlodarski
DPD. Perrotti
D. Perrotti
MMM. Majewski
M. Majewski
LCL. Christensen
L. Christensen
Background: Philadelphia 1 cells are human chronic myelogenous leukemia (CML) cells that contain the BCR/ABL oncogene (a fusion of the BCR and ABL genes). Selective eradication of these cells in vitro can be achieved by combined treatment with antisense phosphorothioate oligodeoxynucleotides ([S]ODNs) specifically targeted to this oncogene (bcr/abl [S]ODNs) and a suboptimal (for use as a single agent) dose of mafosfamide (the in vitro active form of cyclophosphamide). Purpose: We evaluated the ability of bcr/ abl antisense [S]ODNs, alone or subsequent to treatment with a single injection of cyclophosphamide, to suppress the leukemic process induced in severe combined immunodeficient (SCID) mice by Philadelphia 1 cells (i.e., primary CMLblast crisis [CML-BC] cells). In addition, we studied potential mechanisms that might explain the efficacy of the bcr/abl antisense [S]ODN-mafosfamide combination against Philadelphia 1 cells in vitro. Methods: The effects of treating leukemic mice with cyclophosphamide (25 mg/kg body weight; 25% of the dose required to eradicate evidence of leukemia in SCID mice) and/or bcr/abl antisense [S]ODNs were assessed by analysis of survival, by examination of bone marrow for the presence of leukemia cells (using a colony formation assay or using coupled reverse transcription and the polymerase chain reaction to screen for bcr/abl messenger RNA), and by examination of a variety of tissues for the presence of infiltrating leukemia cells. The induction of apoptosis (a cell death program) in vitro in primary CMLBC cells following treatment with bcr/abl antisense [S]ODNs plus or minus prior treatment with mafosfamide was monitored by use of a commercial assay. Relative cellular uptake of [S]ODNs by CML-BC cells treated in vitro with or without prior treatment with mafosfamide was determined by use of confocal microscopy and flow cytometry (for fluorescent [S]ODNs) or by use of blotting techniques that employed radioactively labeled probes (for extracted, unlabeled [S]ODNs). Levels of specific proteins in treated and untreated cells were determined by use of western blotting methods. Reported P values are two-sided. Results: The disease process in leukemic mice was retarded substantially by combination treatment with cyclophosphamide and specific bcr/abl antisense [S]ODNs ( P <.001, relative to treatment with specific antisense [S]ODNs alone, cyclophosphamide alone, or cyclophosphamide plus nonspecific [i.e., control] antisense [S]ODNs); 50% of the mice treated with cyclophosphamide and specific antisense [S]ODNs appeared to be cured of leukemia. The combination treatment was associated with increased induction of apoptosis. In addition, cellular uptake of bcr/abl antisense [S]ODNs appeared to be increased twofold to sixfold by prior treatment with mafosfamide. This increased uptake of [S]ODNs was associated with enhanced suppression of p210bcr/abl protein levels. Conclusions and Implications: Combination therapy with antisense [S]ODNs targeted to specific oncogenes and less toxic doses of anticancer drugs may represent a rational strategy to pursue for the treatment of human leukemias.

19 December 2016 in Bioconjugate Chemistry
Verified
Journal Article
Closed access
MJMarta Janczuk
Marta Janczuk
LRLukasz Richter
Lukasz Richter
GHGrażyna Hoser
Grażyna Hoser
JKJerzy Kawiak
Jerzy Kawiak
MŁMarcin Łoś
Marcin Łoś
RHRobert Holyst
Robert Holyst

1 September 1966 in Transplantation
Verified
Journal Article
Closed access
SMS. Moskalewski
S. Moskalewski
JKJ. Kawiak
J. Kawiak
TRT. Rymaszewska
T. Rymaszewska
SUMMARY Auto- and allogeneic chondrocytes isolated from septal cartilage by enzymic digestion were transplanted into rabbits together with intact fragments of the same cartilage. In other animals fragments only of cartilage were grafted. Cartilage formed by autogeneic chondrocytes was devoid of infiltration, whereas that formed by allogeneic chondrocytes was mostly surrounded by massive infiltration, composed predominantly of lymphocytes and plasma cells. Resorption of such cartilage was also found. Auto- and allogeneic fragments transplanted alone did not evoke infiltrations. When similar fragments were transplanted together with isolated chondrocytes, infiltrations were frequently formed in the vicinity of the allogeneic fragment. It is concluded that isolated allogeneic chondrocytes evoke immunization and may perhaps sensitize the animals against allogeneic fragments of cartilage.